| Breakdown | TTM | Feb 2026 | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 33.57B | 34.24B | 33.39B | 32.22B | 31.49B | 30.01B |
| Gross Profit | 8.63B | 9.05B | 9.08B | 8.52B | 8.51B | 8.46B |
| EBITDA | 2.57B | 2.70B | 3.14B | 2.87B | 2.73B | 3.40B |
| Net Income | 1.44B | 1.62B | 1.74B | 1.66B | 1.49B | 2.39B |
Balance Sheet | ||||||
| Total Assets | 21.40B | 22.67B | 22.11B | 18.26B | 18.13B | 19.05B |
| Cash, Cash Equivalents and Short-Term Investments | 6.23B | 8.08B | 8.95B | 5.46B | 7.31B | 8.01B |
| Total Debt | 83.09M | 0.00 | 12.94M | 0.00 | 1.68M | 3.90M |
| Total Liabilities | 10.46B | 10.40B | 10.08B | 9.60B | 8.90B | 8.53B |
| Stockholders Equity | 10.94B | 12.27B | 12.03B | 8.65B | 9.23B | 10.51B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.15B | 1.82B | 835.18M | 2.02B | 2.84B |
| Operating Cash Flow | 0.00 | 2.00B | 2.45B | 1.65B | 2.78B | 3.61B |
| Investing Cash Flow | 0.00 | -1.17B | -801.30M | -1.03B | -1.02B | -1.01B |
| Financing Cash Flow | 0.00 | -1.70B | 1.84B | -2.47B | -2.47B | 1.45B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥27.03B | 13.79 | ― | 4.01% | -1.66% | -0.76% | |
76 Outperform | ¥32.97B | 17.48 | ― | 5.00% | 2.53% | -6.30% | |
76 Outperform | ¥42.16B | 15.10 | ― | 2.56% | 7.38% | 4.61% | |
75 Outperform | ¥42.56B | 6.09 | ― | 2.28% | 7.47% | 12.35% | |
71 Outperform | ¥36.81B | 17.68 | ― | 3.55% | 3.13% | 6.72% | |
69 Neutral | ¥2.01B | 51.26 | ― | 3.34% | 0.21% | -85.46% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |